Epilepsy and Autism in Children

Why Are Children With Epilepsy More Likely to Have Autism?

The co-occurrence of epilepsy and autism spectrum disorder (ASD) has been recognized for decades, but the new study in Developmental Medicine & Child Neurology offers fresh insight into the biological and clinical factors driving this overlap. Estimates suggest that up to one in five children with epilepsy also meet criteria for ASD — a rate dramatically higher than in the general pediatric population, where prevalence is roughly 1 to 2 percent according to CDC data.

Researchers point to several converging mechanisms. Many genes implicated in epilepsy — including SCN1A, SCN2A, SYNGAP1, and TSC1/TSC2 — are also strongly associated with ASD. These genes regulate neuronal excitability and synaptic function, and disruptions can produce both seizures and the social-communication differences that characterize autism. Tuberous sclerosis complex, for example, is associated with both early-onset epilepsy and a high rate of ASD diagnoses, illustrating how a single genetic condition can manifest along multiple neurodevelopmental dimensions.

Which Children With Epilepsy Are at Highest Risk?

The study identifies several clinical features associated with increased ASD risk among children with epilepsy. Early seizure onset — particularly before age three — appears to be a strong predictor, as does drug-resistant epilepsy and the presence of intellectual disability. Specific epilepsy syndromes, including infantile spasms (West syndrome), Dravet syndrome, and Lennox-Gastaut syndrome, carry especially high comorbidity rates with ASD.

Clinically, these findings reinforce the importance of routine developmental screening for autism in pediatric epilepsy clinics. Earlier identification allows families to access behavioral therapies, speech and language support, and educational accommodations during critical windows of brain development. Neurologists and pediatricians are increasingly being encouraged to integrate ASD screening tools, such as the M-CHAT-R, into standard epilepsy follow-up — particularly for children whose seizures begin in infancy or who present with developmental delays.

What Does This Mean for Treatment and Family Support?

Managing children who have both epilepsy and ASD requires coordinated, multidisciplinary care. Some antiseizure medications — such as valproate — are associated with adverse effects on cognition and behavior, while others may be neutral or beneficial. Treatment plans should weigh seizure control against developmental and behavioral side effects, ideally with input from pediatric neurology, developmental pediatrics, and behavioral specialists.

For families, the dual diagnosis can be overwhelming. Researchers emphasize that early intervention — including applied behavior analysis, occupational therapy, and parent training programs — can meaningfully improve communication, adaptive skills, and quality of life. Public health experts also call for better integration of mental health and educational services, since children with both conditions face higher rates of anxiety and learning difficulties than those with either condition alone.